Corindus Vascular Robotics Introduced into India by Siemens Healthineers

Corindus Vascular Robotics has been introduced into India by Siemens Healthineers, which has included Corindus CorPath GRX, the only FDA cleared and CE certified robotic system for coronary and peripheral vascular interventions, into its portfolio in India.  With state-of-art technology, the company has opened a new field for Advanced Therapies business, tapping into adjacent growth markets with great potential for the future.

Robotic systems for minimally invasive procedures help doctors to precisely control guide catheters, guide wires, and balloon or stent implants via integrated imaging.  The physician does not have to stand at the angiography table, but can control the procedure with a separate controlling module and is therefore protected from radiation.  Recent studies have shown that the CorPath GRX robot system facilitates upto 20 percent reduction in radiation dose to patients.

Cardiovascular diseases (CVDs), especially coronary heart disease (CHD), have assumed epidemic proportions worldwide.  India is fast becoming the world's capital of coronary heart disease and diabetes, a leading cause of mortality in India.  One in 4 deaths in India is because of CVDs, with ischemic heart disease and stroke responsible for more than 80 percent of this burden.  The robotic cardiovascular interventions can aid significantly in the complex medical procedures.  The smart procedural automation can enable performing complex interventional cases in shorter time, with precision, and with better clinical outcomes.

With Corindus technology, Siemens Healthineers is well-positioned to be the leading player in the field of robotic vascular interventions.  Siemens Healthineers products make minimally invasive treatment possible by using high-quality imaging before and during medical interventions, this is now complemented by protection, precision, and standardization through robotic-assisted interventions.